Bleeding And Clotting Disorders Institute Peoria, Illinois

This early-stage study tests whether emicizumab (Hemlibra), given as a shot under the skin, can safely prevent bleeding in people with severe von Willebrand disease or combined VWD/hemophilia A. Currently, severe bleeds require IV infusions of clotting factor. The trial enrolls 4…